Cardiac resynchronisation therapy: evidence based benefits and patient selection.

Area of Science:

• Cardiology
• Medical Technology

Background:

• Heart failure remains a significant clinical challenge despite advances in pharmacologic treatment.
• Cardiac resynchronization therapy (CRT) offers improved outcomes for select heart failure patients.
• Non-response to CRT affects 20-30% of treated individuals.

Purpose of the Study:

• To review the evidence supporting CRT in heart failure management.
• To explore methods for selecting patients most likely to benefit from CRT.

Main Methods:

• Review of large clinical trials on CRT efficacy.
• Discussion of echocardiographic parameters for assessing mechanical dyssynchrony.
• Analysis of patient selection criteria for CRT.

Main Results:

• CRT has demonstrated significant morbidity and mortality benefits in specific heart failure populations (NYHA class III-IV, LVEF ≤35%, QRS duration ≥120 ms).
• A substantial proportion of patients do not respond to CRT.
• Echocardiography shows promise in identifying mechanical dyssynchrony for better patient selection.

Conclusions:

• CRT is a valuable therapy for selected heart failure patients.
• Improved patient selection strategies, potentially involving echocardiography, are crucial to optimize CRT response rates.
• Further research into patient selection for CRT is warranted.